Insider · CIK 0001821353

Dornan David

Reports to the SEC for 3 companies · MORRISTOWN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001821353

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+85.9K sh	—	—	85,887
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+85.9K sh	—	—	85,887
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+85.9K sh	—	—	85,887
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+85.9K sh	—	—	85,887
2026-04-01	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+282K sh	—	—	282,340
2025-03-04	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+688K sh	—	—	687,979
2025-02-15	Elevation Oncology, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+9,375 sh	—	—	9,375
2025-02-15	Elevation Oncology, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−9,375 sh	—	—	28,125
2025-02-15	Elevation Oncology, Inc.F Tax Payment	CHIEF SCIENTIFIC OFFICER	FTax Payment	−4,152 sh	$0.67	−$2,788.898	5,223
2024-02-15	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+225K sh	—	—	225,000
2024-02-15	Elevation Oncology, Inc.Restricted Stock UnitA Award	CHIEF SCIENTIFIC OFFICER	AAward	+37.5K sh	—	—	37,500
2023-02-15	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+130K sh	—	—	130,000
2023-01-06	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+130K sh	—	—	130,000
2022-03-14	Elevation Oncology, Inc.Employee Stock Option (right to buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+230K sh	—	—	230,000
2022-02-18	BOLTBolt Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+210K sh	—	—	210,000
2021-02-04	BOLTBolt Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+110K sh	—	—	110,000

Recent filings

Accepted (ET)
Sep 184/A
Dornan David0001821353-26-000007
SEC(opens sec.gov)
Sep 154
Dornan David0001821353-26-000005
SEC(opens sec.gov)
Apr 34
Dornan David0001821353-26-000003
SEC(opens sec.gov)
Mar 44
Dornan David0001415889-25-006678
SEC(opens sec.gov)
Feb 194
Dornan David0001415889-25-004595
SEC(opens sec.gov)
Feb 204
Dornan David0001415889-24-004392
SEC(opens sec.gov)
Feb 174
Dornan David0001415889-23-002769
SEC(opens sec.gov)
Jan 104
Dornan David0001415889-23-000728
SEC(opens sec.gov)
Mar 164
Dornan David0001209191-22-019286
SEC(opens sec.gov)
Feb 234
Dornan David0000899243-22-007520
SEC(opens sec.gov)
Feb 84
Dornan David0001209191-21-008527
SEC(opens sec.gov)

Companies

Address

C/O WHITEHAWK THERAPEUTICS, INC. 2 HEADQUARTERS PLAZA, EAST BUILDING, 11T

MORRISTOWN, NJ, 07960